Essentials of circulating tumor cells for clinical research and practice - PubMed (original) (raw)
Review
Essentials of circulating tumor cells for clinical research and practice
Marian Liberko et al. Crit Rev Oncol Hematol. 2013 Nov.
Abstract
The major cause of death due to cancer is its metastatic deposit in numerous tissues and organs. The metastatic process requires the migration of malignant cells from primary sites to distant environments. Even for tumors initially spreading through lymphatic vessels, hematogenous transport is the most common metastatic pathway. The detachment of cancer cells from a primary tumor into the blood stream is called epithelial-mesenchymal transition (EMT). As these cells circulate further in the bloodstream they are known as circulating tumor cells (CTCs). The CTC population is highly resilient, enabling the cells to colonize a foreign microenvironment. Alternatively, cancer stem cells (CSCs) may arise from differentiated cancer cells through EMT and an embryonic transdifferentiation process. The presence of CTCs/CSCs in blood seems to be a determining factor of metastasis. This paper reviews various methods of clinical cancer detection as well as the biology and molecular characterization of CTCs/CSCs. Our goal was to summarize clinical studies which used CTC/CSCs for prognosis in patients with breast, colorectal, prostate, lung, ovarian, and bladder cancer.
Keywords: Cancer stem cells; Circulating tumor cells; Clinical significance; Detection methods; Epithelial–mesenchymal transition.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.
Similar articles
- Epithelial-mesenchymal transition: a hallmark in metastasis formation linking circulating tumor cells and cancer stem cells.
Książkiewicz M, Markiewicz A, Zaczek AJ. Książkiewicz M, et al. Pathobiology. 2012;79(4):195-208. doi: 10.1159/000337106. Epub 2012 Apr 4. Pathobiology. 2012. PMID: 22488297 Review. - Clinical and biological significance of circulating tumor cells in cancer.
Masuda T, Hayashi N, Iguchi T, Ito S, Eguchi H, Mimori K. Masuda T, et al. Mol Oncol. 2016 Mar;10(3):408-17. doi: 10.1016/j.molonc.2016.01.010. Epub 2016 Feb 10. Mol Oncol. 2016. PMID: 26899533 Free PMC article. Review. - Prognostic value of cancer stem cells, epithelial-mesenchymal transition and circulating tumor cells in lung cancer.
Pirozzi G, Tirino V, Camerlingo R, La Rocca A, Martucci N, Scognamiglio G, Franco R, Cantile M, Normanno N, Rocco G. Pirozzi G, et al. Oncol Rep. 2013 May;29(5):1763-8. doi: 10.3892/or.2013.2294. Epub 2013 Feb 19. Oncol Rep. 2013. PMID: 23426441 - Classification of circulating tumor cells by epithelial-mesenchymal transition markers.
Wu S, Liu S, Liu Z, Huang J, Pu X, Li J, Yang D, Deng H, Yang N, Xu J. Wu S, et al. PLoS One. 2015 Apr 24;10(4):e0123976. doi: 10.1371/journal.pone.0123976. eCollection 2015. PLoS One. 2015. PMID: 25909322 Free PMC article. - Plastin3 is a novel marker for circulating tumor cells undergoing the epithelial-mesenchymal transition and is associated with colorectal cancer prognosis.
Yokobori T, Iinuma H, Shimamura T, Imoto S, Sugimachi K, Ishii H, Iwatsuki M, Ota D, Ohkuma M, Iwaya T, Nishida N, Kogo R, Sudo T, Tanaka F, Shibata K, Toh H, Sato T, Barnard GF, Fukagawa T, Yamamoto S, Nakanishi H, Sasaki S, Miyano S, Watanabe T, Kuwano H, Mimori K, Pantel K, Mori M. Yokobori T, et al. Cancer Res. 2013 Apr 1;73(7):2059-69. doi: 10.1158/0008-5472.CAN-12-0326. Epub 2013 Feb 1. Cancer Res. 2013. PMID: 23378342
Cited by
- TOPK is highly expressed in circulating tumor cells, enabling metastasis of prostate cancer.
Sun H, Zhang L, Shi C, Hu P, Yan W, Wang Z, Duan Q, Lu F, Qin L, Lu T, Xiao J, Wang Y, Zhu F, Shao C. Sun H, et al. Oncotarget. 2015 May 20;6(14):12392-404. doi: 10.18632/oncotarget.3630. Oncotarget. 2015. PMID: 25881543 Free PMC article. - Circulating tumor cells in colorectal cancer in the era of precision medicine.
Hu M, Wang Z, Wu Z, Ding P, Pei R, Wang Q, Xing C. Hu M, et al. J Mol Med (Berl). 2022 Feb;100(2):197-213. doi: 10.1007/s00109-021-02162-3. Epub 2021 Nov 20. J Mol Med (Berl). 2022. PMID: 34802071 Free PMC article. Review. - Isolation, primary culture, morphological and molecular characterization of circulating tumor cells in gynecological cancers.
Kolostova K, Spicka J, Matkowski R, Bobek V. Kolostova K, et al. Am J Transl Res. 2015 Jul 15;7(7):1203-13. eCollection 2015. Am J Transl Res. 2015. PMID: 26328005 Free PMC article. - Clinical Validation of a Size-Based Microfluidic Device for Circulating Tumor Cell Isolation and Analysis in Renal Cell Carcinoma.
Leitão TP, Corredeira P, Kucharczak S, Rodrigues M, Piairo P, Rodrigues C, Alves P, Cavaco AM, Miranda M, Antunes M, Ferreira J, Palma Reis J, Lopes T, Diéguez L, Costa L. Leitão TP, et al. Int J Mol Sci. 2023 May 7;24(9):8404. doi: 10.3390/ijms24098404. Int J Mol Sci. 2023. PMID: 37176111 Free PMC article. - Prognostic value of preoperative circulating tumor cells counts in patients with UICC stage I-IV colorectal cancer.
Abdalla TSA, Meiners J, Riethdorf S, König A, Melling N, Gorges T, Karstens KF, Izbicki JR, Pantel K, Reeh M. Abdalla TSA, et al. PLoS One. 2021 Jun 10;16(6):e0252897. doi: 10.1371/journal.pone.0252897. eCollection 2021. PLoS One. 2021. PMID: 34111181 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials